Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

“On the Road for Lower Rx Prices” Bus Tour Kick-off Rally, Mon, Sept. 19th

Yes on Prop. 61
Posted on: 16 Sep 16

Yes on Prop. 61:

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160918005002/en/

Image of the side of the 40-foot bus wrapping for the "On the Road for Lower Drug Prices" bus, which kicks off its statewide tour to educate voters and drum upsupport for California's Proposition 61 on September 19th in Los Angeles. (Photo: Business Wire)

WHAT:

     

Supporters of Proposition 61, the California Drug Price Relief Act, will gather at La Placita Olvera, the heart of Los Angeles, to launch the On the Road for Lower Drug Prices, YES ON 61 Tour across California! Coalition members, community leaders and supporters will lay out how Proposition 61 will lower drug prices. Participants and observers will be able to see the 40-foot-long double decker tour bus up close, mingle with neighbors, and grab a bite from local vendors!

 

WHEN:

Monday, 9/19/16 at 12:00PM – 1:30PM

 

WHERE:

La Placita Olvera: 535 N Main St, Los Angeles, CA 90012 ( Directions / Parking )

 

WHO:

Rebekka Armstrong HIV/AIDS Activist

Mary Jo Albert, RN. California Nurses Association (CNA)

Dr. Otto Yang AIDS Healthcare Foundation (AHF)

Steve Dunwoody Vote Vets

Jesse Brooks Patient Advocate & Community Mobilizer

 

Further details on additional statewide stops will be available on our Facebook page!

You can also catch the bus as it makes stops in Orange County, Bakersfield, Modesto, Santa Barbara, Santa Cruz, Oakland, San Diego, Sacramento, Fresno, Riverside, San Francisco, San Jose, and more!

Background

Prop 61 is a simple measure that allows California to leverage its massive negotiating power to achieve lower drug prices for the most vulnerable Californians. Drug companies are scared of Proposition 61 because they know it will put us on the road to lower drug prices!

Proposition 61 would require the state of California to negotiate with drug companies for drug prices that are no more than is paid for the same drugs by the U.S. Department of Veterans Affairs (DVA). Unlike Medicare, the DVA negotiates for drug prices on behalf of the millions veterans it serves, and pays on average 20-24 percent less for medications than other government agencies, and up to 40 percent less than Medicare Part D. Prop. 61 empowers the state, as the healthcare buyer for millions of Californians, to negotiate a better deal for taxpayers, saving the state billions.

Prop 61 Endorsements

Prop. 61 has been endorsed by AARP California, the California Nurses Association, U.S. Sen. Bernie Sanders and his organization Our Revolution, former U.S. Secretary of Labor Robert Reich, civil rights and labor activist Dolores Huerta, Rev. Al Sharpton, the Urban League, AIDS Healthcare Foundation, Campaign for a Healthy California, Progressive Democrats of America, Social Security Works, and the Vote Vets Action Fund. A full list of endorsements can be found at: http://www.yeson61.com/endorsements

www.Yeson61.com

Paid for by Yes on Prop 61, Californians for Lower Drug Prices, With Major Funding by AIDS Healthcare Foundation and California Nurses Association PAC. FPPC ID#1376791

View source version on businesswire.com: http://www.businesswire.com/news/home/20160918005002/en/

Business Wire
www.businesswire.com

Last updated on: 18/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.